-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There has been a breakthrough in the development of traditional Chinese medicine diagnosis and treatment services by Western medicine, which has attracted much attention from the industry
.
.
The Shanghai Municipal Health Commission recently issued the "Administrative Measures for the Practice of Traditional Chinese Medicine Diagnosis and Treatment Activities by Non-Traditional Chinese Medicine Physicians", pointing out that non-Traditional Chinese medicine practitioners in Shanghai have received relevant education or training in traditional Chinese medicine and have passed the assessment .
Scope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Scope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Coincidentally, the "Regulations on Further Strengthening the Work of Integrated Traditional Chinese and Western Medicine (for Trial Implementation)" solicited by the Jilin Provincial Administration of Traditional Chinese Medicine last month also clearly stated that non-TCM physicians should be trained and assessed in accordance with relevant national regulations and be eligible for practice.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
It has attracted much attention for more than two years, and the prescription environment of traditional Chinese medicine in Western medicine has been further optimized, which will inevitably lead to new changes in the traditional Chinese medicine market
.
.
Multidimensional expansion of traditional Chinese medicine
It has become the current development trend to expand the scope of practice of non-TCM physicians, TCM and integrative TCM physicians, and to promote equal emphasis and complementary advantages of TCM and Western medicine
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
On January 12, 2022, the relevant person in charge of the Guangdong Provincial Administration of Traditional Chinese Medicine revealed that the construction of the emergency treatment center of integrated traditional Chinese and Western medicine will be completed with high standards, and a three-level linkage emergency treatment system of integrated traditional Chinese and Western medicine will be established in an all-round way
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
The first change brought about is that the main body of prescribing has been enlarged in an all-round way
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
The number of Chinese medicine personnel in the country
(Source: 2020 Statistical Bulletin on the Development of my country's Health and Wellness)
Secondly, the prescription of traditional Chinese medicine in Western medicine will become more and more professional
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
These actions have changed the situation of "Western medicine restricting the prescribing of traditional Chinese medicine"
.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
How to reshuffle the hundreds of billions of Chinese patent medicine market?
The prescription environment at the terminal of Chinese patent medicine hospitals is further improved, which is expected to reconstruct the competition pattern of large varieties
.
.
Take the recently approved category 1.
1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
Market size of Chinese patent medicine gastric medicine in recent years (unit: ten thousand yuan)
However, the application range of Chinese patent medicines is getting wider and wider, and not all varieties can be exposed to rain and dew.
The test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
The test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
Chinese patent medicine stomach medicine with sales of over 100 million yuan in Chinese public medical institutions in 2020
In 2020, the terminal sales of proprietary Chinese medicines in China's public medical institutions will be about 240 billion yuan
.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
In addition, there is a new phenomenon worthy of attention: at the end of December 2021, Wanbangde and Beijing Yingke Rui announced the comprehensive development of Chinese patent medicine research and development cooperation, and agreed to transfer Yingke Rui's "Class 1.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
At present, Chinese medicine companies invest very little in research and development, and many listed Chinese medicine companies invest less than 1% of their total revenue in research and development
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
There has been a breakthrough in the development of traditional Chinese medicine diagnosis and treatment services by Western medicine, which has attracted much attention from the industry
.
.
The Shanghai Municipal Health Commission recently issued the "Administrative Measures for the Practice of Traditional Chinese Medicine Diagnosis and Treatment Activities by Non-Traditional Chinese Medicine Physicians", pointing out that non-Traditional Chinese medicine practitioners in Shanghai have received relevant education or training in traditional Chinese medicine and have passed the assessment .
Scope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Scope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Coincidentally, the "Regulations on Further Strengthening the Work of Integrated Traditional Chinese and Western Medicine (for Trial Implementation)" solicited by the Jilin Provincial Administration of Traditional Chinese Medicine last month also clearly stated that non-TCM physicians should be trained and assessed in accordance with relevant national regulations and be eligible for practice.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
It has attracted much attention for more than two years, and the prescription environment of traditional Chinese medicine in Western medicine has been further optimized, which will inevitably lead to new changes in the traditional Chinese medicine market
.
.
Multidimensional expansion of traditional Chinese medicine
It has become the current development trend to expand the scope of practice of non-TCM physicians, TCM and integrative TCM physicians, and to promote equal emphasis and complementary advantages of TCM and Western medicine
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
On January 12, 2022, the relevant person in charge of the Guangdong Provincial Administration of Traditional Chinese Medicine revealed that the construction of the emergency treatment center of integrated traditional Chinese and Western medicine will be completed with high standards, and a three-level linkage emergency treatment system of integrated traditional Chinese and Western medicine will be established in an all-round way
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
The first change brought about is that the main body of prescribing has been enlarged in an all-round way
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
The number of Chinese medicine personnel in the country
(Source: 2020 Statistical Bulletin on the Development of my country's Health and Wellness)
Secondly, the prescription of traditional Chinese medicine in Western medicine will become more and more professional
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
These actions have changed the situation of "Western medicine restricting the prescribing of traditional Chinese medicine"
.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
How to reshuffle the hundreds of billions of Chinese patent medicine market?
The prescription environment at the terminal of Chinese patent medicine hospitals is further improved, which is expected to reconstruct the competition pattern of large varieties
.
.
Take the recently approved category 1.
1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
Market size of Chinese patent medicine gastric medicine in recent years (unit: ten thousand yuan)
However, the application range of Chinese patent medicines is getting wider and wider, and not all varieties can be exposed to rain and dew.
The test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
The test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
Chinese patent medicine stomach medicine with sales of over 100 million yuan in Chinese public medical institutions in 2020
In 2020, the terminal sales of proprietary Chinese medicines in China's public medical institutions will be about 240 billion yuan
.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
In addition, there is a new phenomenon worthy of attention: at the end of December 2021, Wanbangde and Beijing Yingke Rui announced the comprehensive development of Chinese patent medicine research and development cooperation, and agreed to transfer Yingke Rui's "Class 1.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
At present, Chinese medicine companies invest very little in research and development, and many listed Chinese medicine companies invest less than 1% of their total revenue in research and development
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
There has been a breakthrough in the development of traditional Chinese medicine diagnosis and treatment services by Western medicine, which has attracted much attention from the industry
.
.
The Shanghai Municipal Health Commission recently issued the "Administrative Measures for the Practice of Traditional Chinese Medicine Diagnosis and Treatment Activities by Non-Traditional Chinese Medicine Physicians", pointing out that non-Traditional Chinese medicine practitioners in Shanghai have received relevant education or training in traditional Chinese medicine and have passed the assessment .
Scope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Traditional Chinese Medicine Traditional Chinese MedicineScope related Chinese medicine diagnosis and treatment activities
.
At the same time, non-traditional Chinese medical practitioners are encouraged to learn and use traditional Chinese medicine diagnosis and treatment techniques
.
Coincidentally, the "Regulations on Further Strengthening the Work of Integrated Traditional Chinese and Western Medicine (for Trial Implementation)" solicited by the Jilin Provincial Administration of Traditional Chinese Medicine last month also clearly stated that non-TCM physicians should be trained and assessed in accordance with relevant national regulations and be eligible for practice.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
Chinese medicine practitioners can adopt TCM technical methods related to their specialty, and issue Chinese patent medicine prescriptions in accordance with the basic TCM clinical syndrome differentiation and treatment principles.
Eligible non-Traditional Chinese medicine practitioners can provide all TCM services
.
It has attracted much attention for more than two years, and the prescription environment of traditional Chinese medicine in Western medicine has been further optimized, which will inevitably lead to new changes in the traditional Chinese medicine market
.
.
Multidimensional expansion of traditional Chinese medicine
Multidimensional expansion of traditional Chinese medicine It has become the current development trend to expand the scope of practice of non-TCM physicians, TCM and integrative TCM physicians, and to promote equal emphasis and complementary advantages of TCM and Western medicine
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
.
It is not difficult to judge that more provinces and cities will introduce similar policies in the future to further break the bottleneck of the practice of integrated traditional Chinese and Western medicine in medical institutions
.
On January 12, 2022, the relevant person in charge of the Guangdong Provincial Administration of Traditional Chinese Medicine revealed that the construction of the emergency treatment center of integrated traditional Chinese and Western medicine will be completed with high standards, and a three-level linkage emergency treatment system of integrated traditional Chinese and Western medicine will be established in an all-round way
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
.
Judging from the actions of major medical provinces and cities such as Shanghai and Guangdong, the use of traditional Chinese medicine technology in Western medicine will have a clear guarantee at the institutional level in the future
.
The first change brought about is that the main body of prescribing has been enlarged in an all-round way
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
.
According to the "2020 Statistical Bulletin on the Development of China's Health and Wellness", as of the end of 2020, there were 4.
086 million practicing (assistant) physicians in China, of which 683,000 were practicing (assistant) physicians in the category of traditional Chinese medicine, which is only equivalent to practicing (assistant) physicians nationwide.
one-sixth of the total
.
If more and more western physicians come to learn and apply TCM techniques, the number of subjects who prescribe TCM will increase significantly
.
The number of Chinese medicine personnel in the country
(Source: 2020 Statistical Bulletin on the Development of my country's Health and Wellness)
Secondly, the prescription of traditional Chinese medicine in Western medicine will become more and more professional
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
.
Non-TCM physicians need to pass relevant education and training and pass the examination, and then carry out the application of traditional Chinese medicine technology, and the professional knowledge of traditional Chinese medicine in Western medicine is more systematic
.
For example, the Jiangsu Health and Health Commission has previously issued a notice: Eligible primary-level practitioners and rural doctors can prescribe common and frequently-occurring traditional Chinese medicine prescriptions, including long-term prescriptions, and long-term prescriptions of commonly used traditional Chinese medicines for chronic diseases
.
It can be seen that the ban on the prescribing of proprietary Chinese medicines by Western medicine in medical institutions at and below the county level has been basically lifted
.
More importantly, these grass-roots physicians must have the level of traditional Chinese medicine services
.
These actions have changed the situation of "Western medicine restricting the prescribing of traditional Chinese medicine"
.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
medicines medicines medicines.
On July 1, 2019, the National Health and Medical Commission issued the "Notice on Printing and Distributing the First Batch of National Key Monitoring and Rational Drug Lists (Chemical Drugs and Biological Products)", which restricted the prescription of traditional Chinese medicines and proprietary Chinese medicines.
Only qualified doctors can prescribe medicines
.
At that time, it caused panic in the market.
You must know that about 70% of clinical prescriptions of Chinese patent medicines come from Western medicine
.
Nowadays, it is good for the Chinese patent medicine market to encourage and promote western medicine to learn Chinese medicine and apply Chinese medicine's syndrome differentiation and treatment method
.
How to reshuffle the hundreds of billions of Chinese patent medicine market?
How to reshuffle the hundreds of billions of Chinese patent medicine market? The prescription environment at the terminal of Chinese patent medicine hospitals is further improved, which is expected to reconstruct the competition pattern of large varieties
.
.
Take the recently approved category 1.
1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
medicine medicine medicine1 innovative traditional Chinese medicine Qirui Weishu Capsule as an example.
The curative effect is remarkable
.
The market size of Chinese patent medicine stomach medicine has exceeded 10 billion yuan in 2019, and the hospital terminal is the main battlefield, accounting for over 70%
.
In the first half of 2021, the market size of Chinese patent medicine gastric medicine in public medical institutions in China increased by 17.
14%
.
Once the development of traditional Chinese medicine services by western medicine is further released, the Chinese patent medicine stomach medicine market will surely rise to a higher level
.
Market size of Chinese patent medicine gastric medicine in recent years (unit: ten thousand yuan)
However, the application range of Chinese patent medicines is getting wider and wider, and not all varieties can be exposed to rain and dew.
The test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
enterprise enterprise enterpriseThe test is still the clinical evidence of different products and the academic promotion ability of enterprises
.
There are more than 10 gastric medicine products with sales of more than 100 million yuan in the terminal Chinese patent medicine market of public medical institutions in China.
Among them, Kangfuxin liquid occupies the first place with sales of more than 2 billion yuan, and the gap between the second product and the second product is widening.
bigger
.
Analyzing the four domestic rehabilitation new liquid varieties, the market promotion coverage of the theater channel is the common feature of its steady increase in sales
.
Then, it is worth observing whether the listing of Qirui Weishu Capsules will bring about new changes in the market structure of gastric medicines
.
Chinese patent medicine stomach medicine with sales of over 100 million yuan in Chinese public medical institutions in 2020
In 2020, the terminal sales of proprietary Chinese medicines in China's public medical institutions will be about 240 billion yuan
.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
hospital hospital hospital.
Among the 13 treatment categories of proprietary Chinese medicines, the top three drugs for cardiovascular and cerebrovascular diseases, drugs for respiratory diseases and drugs for musculoskeletal diseases have a market size of over 10 billion
.
And in the first quarter of 2021, 16 of the top 20 sales of proprietary Chinese medicines in public hospitals
in key cities are exclusive products .
From the perspective of sales growth, more than 80% of products have positive growth
.
In 2020, only 3 of the TOP20 products have positive growth.
After more western medicine is learned and applied in traditional Chinese medicine diagnosis and treatment, the prescription behavior will be fully optimized
.
In addition, there is a new phenomenon worthy of attention: at the end of December 2021, Wanbangde and Beijing Yingke Rui announced the comprehensive development of Chinese patent medicine research and development cooperation, and agreed to transfer Yingke Rui's "Class 1.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
1 innovative traditional Chinese medicine pharmacology" for 10.
2 million yuan.
51% property rights of "Xiaopi Granules" clinical trial license and its technical secrets
.
At present, Chinese medicine companies invest very little in research and development, and many listed Chinese medicine companies invest less than 1% of their total revenue in research and development
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
.
The model of Wanbangde and Yingkerui may bring a new trend and crack the shortcomings of Chinese patent medicine innovation
.
The successive approvals of innovative Chinese medicines will inevitably create opportunities for high-quality and affordable Chinese patent medicines to stand out and create a large variety of traditional Chinese medicines in the new era.
In the future, the premise is that more Western medicines prescribe Chinese patent medicines and are more standardized.
, more professional
.
